Log In
Friday 21st October 2016

Jab to halt cancer

12th July 2010

Researchers at Middlesex University have developed an injection which could help to prevent cancerous tumours from metastasising.


The drug is already in use on cancer patients and has been found to reduce the size of tumours and stop them spreading.

The creator of the treatment, Professor Ray Iles, said many deaths could be prevented by the vaccine and it could be used to treat breast, bowel and cervical cancer.

The team discovered that many tumours produce a type of hormone which is normally only created when a woman is pregnant.

The presence of human chorionic gonadotropin (hCG) is used in pregnancy tests to determine if a woman is pregnant.

The researchers discovered that a type of hCG is also produced by about 50% of bladder and pancreatic cancers.

Certain types of breast, bowel, ovarian and cervical tumours also produce the hormone.

The jab, which is being produced with assistance from the American company Celldex Therapeutics, boosts the immune system and helps it to eradicate hCG.

Professor Iles said: "Not only are you causing the cancer to shrink, it is not metastasising. If you come in with chemotherapy and surgery, you've got a cure."

The treatment is now being tested on 60 patients who have been recently diagnosed with bladder cancer.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016